z-logo
open-access-imgOpen Access
Comparison of CRISPR Genomic Tagging for Affinity Purification and Endogenous Immunoprecipitation Coupled with Quantitative Mass Spectrometry To Identify the Dynamic AMPKα2 Interactome
Author(s) -
Benjamin D. Stein,
Sébastien Herzig,
Salvador MartínezBartolomé,
Mathieu LavalléeAdam,
Reuben J. Shaw,
John R. Yates
Publication year - 2019
Publication title -
journal of proteome research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.644
H-Index - 161
eISSN - 1535-3907
pISSN - 1535-3893
DOI - 10.1021/acs.jproteome.9b00378
Subject(s) - interactome , crispr , immunoprecipitation , computational biology , epitope , proteomics , biology , ampk , endogeny , protein–protein interaction , genome editing , gene , protein kinase a , microbiology and biotechnology , genetics , phosphorylation , biochemistry , antibody
Recent advances in genome editing technologies have enabled the insertion of epitope tags at endogenous loci with relative efficiency. We describe an approach for investigation of protein interaction dynamics of the AMP-activated kinase complex AMPK using a catalytic subunit AMPKα2 ( PRKAA2 gene) as the bait, based on CRISPR/Cas9-mediated genome editing coupled to stable isotope labeling in cell culture, multidimensional protein identification technology, and computational and statistical analyses. Furthermore, we directly compare this genetic epitope tagging approach to endogenous immunoprecipitations of the same gene under homologous conditions to assess differences in observed interactors. Additionally, we directly compared each enrichment strategy in the genetically modified cell-line with two separate endogenous antibodies. For each approach, we analyzed the interaction profiles of this protein complex under basal and activated states, and after implementing the same analytical, computational, and statistical analyses, we found that high-confidence protein interactors vary greatly with each method and between commercially available endogenous antibodies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here